Objectives: Detection and characterization of extended-spectrum b-lactamases (ESBLs) and AmpC-encoding genes was conducted in German Salmonella isolated from different sources from 2003 to 2007.
Introduction
Over the last decade, the high incidence of multidrug resistance in Enterobacteriaceae has become a serious public health problem worldwide. Because of their critical importance for human and veterinary medicine, 1 resistance to extended spectrum b-lactams, especially third-and fourth-generation cephalosporins and penems, is of special interest. To date, .700 distinct b-lactamases have been described 2 and they can be classified following the Ambler or the Bush -Jacoby -Medeiros schemes. 3, 4 The extended-spectrum b-lactamases (ESBLs) belong to class A in the Ambler scheme and to group 2be in the Bush -Jacoby-Medeiros scheme. Since their first description in the early 1980s in Germany, 5 the number of ESBL-producing bacteria has increased worldwide in many different genera of Enterobacteriaceae. 6 Most of these enzymes are derivatives of the TEM or SHV b-lactamases that can hydrolyse most penicillins as well as oximino-cephalosporins and are inhibited by clavulanic acid. However, in recent years a new family of ESBLs with a higher level of resistance to cefotaxime than to ceftazidime has arisen. These enzymes are called CTX-M b-lactamases and they can be subdivided into five subgroups by their amino acid sequence similarities: CTX-M-1; CTX-M-2; CTX-M-8; CTX-M-9; and CTX-M-25. The genes encoding these enzymes have commonly been found located on plasmids and are nowadays considered the most prevalent type of ESBLs in many European countries. 7, 8 In contrast, AmpC enzymes belong to class C in Ambler's genetic classification and to group 1 in the Bush-Jacoby-Medeiros scheme. These enzymes mediate resistance to all b-lactams except carbapenems, cefepime, cefpirome and the novel penicillin amdinocillin, and most of them are clavulanic acid-resistant.
The increasing presence of these b-lactamases in pathogenic bacteria limits the therapeutic use of these drugs. 9 Reports that reflect the incidence and molecular epidemiology of b-lactamases in food-producing animals are of special interest, since they are the principal reservoir of zoonotic pathogens. Some recent studies have documented the present situation in different European countries, 10, 11 but data from Germany are currently unavailable. For this reason, the aim of this study was to identify ESBL-and AmpC-producing Salmonella enterica isolates, mainly from animal and food origin, isolated from all over the country, and collected at the German National Salmonella Reference Laboratory (NRL-Salm) during the period 2003 -07.
Materials and methods

Bacterial isolates
NRL-Salm, part of the Federal Institute for Risk Assessment (BfR, Berlin), receives Salmonella strains isolated in all Federal Länder of Germany, originating from routine surveys of different investigation centres involved in public health, for further typing (including serotyping, phage typing and antimicrobial susceptibility assays). During the period 2003-07, a total of 22679 Salmonella enterica isolates were collected at the NRL-Salm. These isolates originated from foodproducing animals (38%), foods (30%), non-food-producing animals (13%), feed (8%), environment (7%), humans (2%) or unknown sources (2%). In order to detect ESBL and AmpC producers among these strains, all German isolates showing MICs of 4 mg/L to ceftiofur, avoiding isolates with same date or place of isolation, were included in this study (initially, isolates with MIC values of 2 mg/L were also considered but later excluded, because further analysis confirmed their susceptibility to most b-lactams). Forty-five isolates belonging to serovars Salmonella Saintpaul (19), Salmonella Typhimurium (10), Salmonella Agona (5), Salmonella Paratyphi B dTþ (5), Salmonella Anatum (2), Salmonella Infantis (1), Salmonella Kentucky (1), Salmonella London (1) and Salmonella Virchow (1) were analysed. However, by isoelectric focusing (IEF) and PCR/ sequencing, the 19 Salmonella Saintpaul isolates were only positive for the narrow-spectrum b-lactamase TEM-1, which could not explain their resistance phenotype. None of the ESBLs or AmpC enzymes screened for were found. For this reason only the work regarding the remaining 26 isolates is presented.
Antimicrobial susceptibility testing
The MICs of 17 antimicrobial agents, including b-lactams and b-lactamase inhibitors (ampicillin, ceftiofur and amoxicillin/clavulanic acid), were assessed using the CLSI broth microdilution method.
12,13 The isolates were also tested against a panel of 12 additional b-lactams (Oxoid, Wesel, Germany)-aztreonam, cefotaxime, cefoxitin, cefepime, cefpodoxime, ceftazidime, ceftriaxone, cefuroxime, cefalotin, imipenem, piperacillin and ticarcillin-by the CLSI disc-diffusion method.
14,15
Detection and characterization of ESBLs and AmpC enzymes and genes This was achieved by both PCR amplification/sequencing of selected genes and IEF of the enzymes.
In order to detect the presence of b-lactamases in the isolates, different PCR amplifications were performed in three steps, depending on the b-lactam resistance phenotypes found. First, the isolates were tested for the presence of bla OXA , bla PSE and bla TEM genes using a multiplex PCR with primers specific for these genes. 16 In the second step, the presence of bla CTX-M genes was investigated in all isolates by a screening PCR with universal primers for bla CTX-M -like genes. 17 The positive isolates detected were further analysed by simple PCRs using specific primers for the bla CTX-M groups M-1, M-8 and M-9. 17, 18 In the third step, isolates were analysed using a multiplex PCR for the detection of family-specific plasmid-mediated AmpC b-lactamase genes (ACC, CIT, DHA, EBC, FOX and MOX) 19 and by simple PCR with primers for bla CMY . 20 All PCR products obtained by amplification of bla CTX-M groups and bla CMY were sequenced by Agowa GmbH (Berlin, Germany). Sequences obtained were compared with those registered in databases.
The genetic environment of the bla CTX-M genes was also investigated by PCR and sequencing, using forward primers specific for IS26 and ISEcp1 and the bla CTX-M reverse consensus primer (MA1-R), as described by Eckert et al. 21 The generated sequences were deposited in the EMBL database with accession numbers FM865623, FM865624 and FM865625.
The isoelectric point ( pI) of the b-lactamases was determined by IEF. Crude extracts were prepared by sonication of cell pellets obtained from overnight cultures grown in Luria -Bertani broth containing ampicillin (100 mg/L). Pellets were washed twice with phosphate buffer ( pH 7.0), sonicated on ice, centrifuged, filtered and stored at 220 or 2808C. Bacterial extracts (3 mL) were loaded onto commercial gels (PhastGel IEF 3-9, 4-6.5 or 5 -8; GE Healthcare, Freiburg, Germany). IEF was carried out on a Phast System (GE Healthcare) following the manufacturer's recommendations. Protein development was done by overlaying the gels with 500 mL of nitrocefin 50 mg/L solution (Oxoid, Wesel, Germany). A collection of ESBL-positive strains kindly provided by the EU Reference Laboratory for Antimicrobial Resistance (CRL-AR, Copenhagen, Denmark) were used as controls.
Other resistance genes and integron detection
The isolates were also analysed for additional resistance genes related to their resistance phenotypes. Overall, genes encoding resistance to chloramphenicol (catA1, cmlA, floR), gentamicin (aacC2, aacC4, aadB), kanamycin (aphA1, aphA2), quinolones (qnrA, qnrB, qnrS), streptomycin (aadA1, aadA2, strA-strB), sulphonamides (sul1, sul2, sul3), tetracycline [tet(A), tet(B), tet(G)] and trimethoprim (dfrA1, dfrA5-14, dfrA7-17, dfrA12) were screened for by PCR, as previously described. 16,22 -26 To establish the genetic background of nalidixic acid resistance, PCR amplification/sequencing of the gyrA genes was performed. 27 The presence of class 1 and class 2 integrons was investigated by using the 5 0 CS/3 0 CS and hep74/hep51 primers to amplify their variable regions. 28 Gene cassettes inserted therein were identified by DNA sequencing of the amplicons.
Plasmid analysis, hybridization procedures and genomic macrorestriction
Plasmid DNA was extracted from the S. enterica isolates using the Kado and Liu method, 29 followed by vertical agarose gel electrophoresis. The Kado gels were transferred onto membranes and hybridized with selected probes for the different b-lactamases, using previously described methods. 16 Conjugation experiments were performed as reported, 28 using representative strains of each plasmid profile as donors and the rifampicin-resistant strain Escherichia coli K12 J53 as recipient. In order to classify the plasmids harbouring b-lactamases into incompatibility groups, the PCR-based inc/rep typing method described by Carattoli et al. 30 was applied. For this purpose, the transconjugants and the strain Salmonella Paratyphi B dTþ 03-03096 were used as sources of template DNA. Plasmid profiles and hybridization results are shown in Figure S1 [available as Supplementary data at JAC Online (http://jac.oxfordjournals.org/)].
Genomic DNA from the S. enterica representative isolates was subjected to macrorestriction analysis with XbaI endonuclease. Digestions were also performed with S1 nuclease in order to visualize the plasmids and determine their size more accurately. The fragments generated were separated by PFGE using the CHEF-DRIII SYS220/240 system (Bio-Rad Laboratories, Madrid, Spain). Agarose plug preparation and PFGE running conditions were performed following the PulseNet standardized protocol (http://www. pulsenet-europe.org).
Results
On the basis of their susceptibility to b-lactamase inhibitors and different generations of cephalosporins, presence of genes detected by PCR/sequencing, and IEF of the enzymes, all 26 isolates could be assigned to one of four groups.
Group 1: bla CTX-M -positive isolates
Sixteen isolates (10 Salmonella Typhimurium, 2 Salmonella Anatum, 2 Salmonella Paratyphi B dT þ, 1 Salmonella Infantis and 1 Salmonella London) were susceptible to imipenem and cefoxitin but resistant to ampicillin, piperacillin, ticarcillin, cefalotin, cefuroxime, cefotaxime, ceftriaxone and cefpodoxime. They were intermediate or resistant to aztreonam, and intermediate or susceptible to cefepime and amoxicillin/clavulanic acid. Most isolates showed a wider zone of inhibition by the interaction between amoxicillin/clavulanic acid and the third-and fourth-generation cephalosporins. All these data suggested the presence of genes belonging to the family bla CTX-M , which was confirmed by PCR/sequencing. Fifteen isolates were positive for bla CTX-M-1 and one for bla CTX-M-15 (the only one that was resistant to ceftazidime), genes that encode cefotaximases with an alkaline pI value (both pI 8.9). Additional b-lactamases could also be detected in the Salmonella Typhimurium isolates (Table 1) .
In nine of the 16 isolates, two insertion sequences, IS26 and ISEcp1, were identified by PCR upstream of the bla CTX-M-1 gene, yielding products of 735 and 422 bp, respectively. Sequence analysis of the amplicons revealed that in these isolates the ISEcp1 was located 80 bp upstream of bla CTX-M-1 . However, ISEcp1 appeared truncated at the 3 0 -end of the tnpA gene by the insertion of IS26. This structure was detected in all isolates with plasmids of incompatibility groups IncB/0 and IncN, and in the four isolates that were positive for both IncI1 and IncN (Table 1) .
In six isolates the PCR performed with primers IS26F and MA1-R yielded no amplicons, and only the insertion sequence (ISEcp1) was detected 80 bp upstream of the start codon of bla CTX-M-1 . The amplicon obtained was 422 bp in length and was identical to the 422 bp fragment yielded in the previous group of isolates. This organization was present in all isolates with IncI1 plasmids, except for Salmonella Typhimurium 05-01901. This isolate was the only one that harboured a bla CTX-M-15 gene and yielded a PCR product of 390 bp with the ISEcp1F and MA1-R primers. Sequence analysis identified the insertion sequence only 48 bp upstream of the start codon of the bla CTX-M-15 gene.
All Salmonella Typhimurium (10) and one Salmonella Paratyphi B dTþ isolates contained class 1 integrons (Table 1) . Seven Salmonella Typhimurium isolates carried two class 1 integrons with variable regions of 800 bp/aadB and 1200 bp/bla PSE-1 together with other resistance genes related to the presence of a variant of the Salmonella Genomic Island SGI-1 (Table 1) . Additional hybridization experiments using probes for the floR, tet(G) and sul1 genes confirmed the presence of the variant SGI1-M in all of them.
31 Class 2 integrons, with the variable region 2300 bp/dfrA1-sat2-aadA1 responsible for the resistance to trimethoprim and streptomycin (Table 1) , were only detected in the two Salmonella Paratyphi B dTþ isolates.
The hybridization and conjugation experiments demonstrated that in all cases bla CTX-M-1 and bla CTX-M-15 were located on selftransferable plasmids of variable sizes, belonging to different incompatibility groups (Table 1 ). The two strains showing the plasmid profile P6 carried an additional plasmid of 120 kb with the bla TEM-1 ( Figure S1 ) and conjugation experiments showed that both plasmids (35 and 120 kb) were conjugative. Depending on the antibiotic used for selection (ampicillin or cefalotin), transconjugants positive for bla TEM-1 (harbouring the 120 kb plasmid) or for bla CTX-M-1 (with the 35 kb plasmid) could be obtained. The profile P7 comprised two plasmids of 80 and 35 kb, with bla CTX-M-1 located on the smallest one (Table 1, Figure S1 ). However, in conjugation experiments, both plasmids were transferred together to the E. coli transconjugants, probably because the bla CTX-M-1 -positive plasmid was mobilized by the other.
A total of eight different XbaI PFGE macrorestriction profiles were identified in this group (Table 1, Figure 1 ). The seven Salmonella Typhimurium isolates positive for the SGI1-M shared a characteristic profile (frequent in DT104 strains), with variations related to the presence of plasmids. The Salmonella Paratyphi B dTþ isolates also presented a common pattern, typical for a predominant German Salmonella Paratyphi B dTþ clone (Figure 1 ). 32 
Group 2: ampC-positive isolates
Six isolates (five Salmonella Agona and one Salmonella Kentucky) resistant to ampicillin, piperacillin, amoxicillin/clavulanic acid, cefalotin, cefoxitin, cefuroxime and to the thirdgeneration cephalosporins, intermediate or resistant to ticarcillin and aztreonam, but susceptible to imipenem and cefepime, were selected as possible AmpC producers and characterized genetically. In all of them the presence of the gene bla CMY-2 was confirmed (Table 1) . IEF showed a high pI value (9) for all the extracts. These six isolates were negative for the presence of class 1 integrons. In all isolates, the bla CMY-2 gene was located in an 90 kb conjugative plasmid belonging to the incompatibility group I1 (Table 1, Figure S1 ). The Salmonella Kentucky isolate carried two plasmids more ( Figure S1 ) and, after conjugation experiments, all E. coli transconjugants obtained harboured the 90 kb bla CMY-2 -positive plasmid together with another one of 40 kb. PFGE using XbaI showed that the Salmonella Agona isolates had the same pattern and may be clonally related (Figure 1 ).
Group 3: bla TEM-52 -positive isolates
One Salmonella Paratyphi B dTþ and one Salmonella Virchow isolate showed a resistance pattern similar to that of the bla CTX-M group, but with intermediate or full resistance to ceftriaxone, cefotaxime and ceftazidime. No bla CTX-M or ampC gene could be detected, but a bla TEM gene was present in the isolates. The determination of the isoelectric point from the cellular extracts was essential to identify the ESBL. A unique band was observed by IEF corresponding to a TEM b-lactamase with a pI of 6, higher than the expected value of 5.4, characteristic for TEM-1. Lastly, PCR/sequencing identified the bla TEM-52 gene. The Salmonella Paratyphi B dTþ isolate also carried the class 2 integron with the 2300 bp variable region cited above. In both isolates, the bla TEM-52 was located on an 80 kb plasmid belonging to the IncI1 group ( Figure S1 ), which was successfully transferred alone to E. coli by conjugation.
Group 4: bla TEM-20 -positive isolates
Two Salmonella Paratyphi B dTþ isolates showed a resistance pattern similar to the two isolates from the previous group, but were susceptible to ceftazidime (Table 1) . Cellular extracts showed a unique enzyme with a pI of 5.4, normally characteristic for bla TEM-1 . However, this gene alone could not explain the resistance phenotype of the strains and DNA sequencing of the amplification product identified the bla TEM-20 ESBL gene. Class 1 integrons were not detected, but the isolates also carried class 2 integrons ( Table 1 ). The bla TEM gene mapped on an IncI1 plasmid of 85 kb, which could be successfully transferred to E. coli by conjugation in only one isolate. In strain Salmonella Paratyphi B dTþ 03-03096 the conjugation was not possible under the conditions tested.
Discussion
All Salmonella isolates received by NRL-Salm during 2003 -07 were tested for their resistance against several antimicrobials, including ceftiofur as a third-generation cephalosporin, using the breakpoints set by the CLSI. 13 During recent years, approaches to harmonize testing methods and panels of antimicrobials, as well as breakpoints to carry out monitoring of antimicrobial resistance, have been performed in Europe. 33 As a consequence, the panel of antimicrobials and breakpoints used in our laboratory has changed since January 2008 following the new EU The sizes of the plasmids were accurately estimated by S1-PFGE (data not shown). Resistance phenotype assessed by broth microdilution as described in Schroeter et al. ESBLs and AmpC b-lactamases in Salmonella guidelines. 33 Now cefotaxime and ceftazidime are tested instead of ceftiofur, and the harmonized cut-off values set by the European Committee on Antimicrobial Susceptibility Testing (EUCAST) (http://www.eucast.org) are applied. 33 How this change will affect the detection of ESBLs or AmpC-positive isolates will be evaluated in the upcoming years.
Ceftiofur is exclusively used in veterinary medicine. In Germany it is allowed for treatment of cattle and swine, whereas cefquinome is allowed for cattle, horses and swine. No third-or fourth-generation cephalosporins are legally allowed for the treatment of poultry. During the period 2003 -07, 0.4% of the Salmonella isolates tested at the NRL-Salm showed resistance to ceftiofur.
Several studies have shown that in most of the Northern European countries, the prevalence of ESBL-or AmpC-carrying isolates is still low in comparison to Southern and Eastern European countries. In the countries neighbouring Germany, such as the Netherlands, Denmark and France, this prevalence is continuously rising. 10, 11 The CTX-M-1 and CTX-M-9 enzyme families of ESBLs are currently among those most frequently detected in European clinical and animal isolates of Enterobacteriaceae. 7,8,10,11,17,34 -36 CTX-M-1 was the predominating group in our series (isolates carried genes encoding CTX-M-1 or CTX-M-15), but no isolate producing b-lactamases from the CTX-M-9 group (i.e. CTX-M-9 or CTX-M-14) could be detected. The bla CTX-M-1 and bla CTX-M-15 genes are usually located on large plasmids. 34, 36, 37 Our study confirms this observation, since all CTX-M-1-positive strains carried the gene on self-transferable plasmids of between 30 and 130 kb. As reported for other European countries, most of those plasmids belonged to the IncI1 and IncN incompatibility groups. 34, 38, 39 Interestingly, the CTX-M-15 enzyme was only detected in one DT104L isolate from a horse. This is remarkable, because the encoding gene was located on a plasmid belonging to the IncI1 group, a fact scarcely reported in S. enterica.
40
A remarkable relationship of bla CTX-M -positive strains to insertion elements was observed. In all isolates a complete or deleted copy of the insertion sequence ISEcp1 was detected upstream of the start codon of the ESBL gene. IS26 was found upstream of the deleted ISEcp1 in nine bla CTX-M-1 -positive isolates. Therefore, it can be speculated that the insertion of ISEcp1 occurred first, which was followed by integration of IS26, partially disrupting the first inserted element. This configuration, although already observed in other enterobacterial species such as E. coli (accession no. FJ235692) and Proteus mirabilis (accession no. AJ416342), is reported here for first time in S. enterica. In the rest of our isolates, including the bla CTX-M-15 -positive Salmonella Typhimurium, only a copy of the ISEcp1 element was associated with the ESBL gene. These results highlight once again the role of ISEcp1 in the mobilization and expression of different b-lactamase genes. 37, 41 Other ESBLs identified in this study were bla TEM-20 in Salmonella Paratyphi B dTþ (two isolates) and bla TEM-52 in Salmonella Paratyphi B dTþ and Salmonella Virchow (one isolate each). The low frequency of these enzymes observed in this work is in agreement with the current situation in Europe, where the TEM and SHV enzyme variants are reported nowadays to a lesser extent than the CTX-M enzymes. 7, 8, 10 Despite this, the TEM-52 variant was detected as the most prevalent, and TEM-20 was identified at lower frequency in a study performed on Salmonella isolated from poultry, poultry products and human patients in the Netherlands. 42 Other Salmonella or E. coli TEM-52 producers were also found recently in animal and human isolates from several European countries. 43 -45 In our study, both TEM-52 and TEM-20 variants were associated with plasmids belonging to IncI1 incompatibility groups as described for the TEM-52 producer isolates from Belgium and France, and for TEM-20 from Norway. 43, 45 The only AmpC enzyme identified in this study was CMY-2, the CMY enzyme most frequently reported in E. coli, Klebsiella pneumoniae and Salmonella spp. 35 This b-lactamase has been previously found in samples from ill and healthy animals as well as in human clinical isolates worldwide. 9, 46, 47 Despite being considered as prevalent among extended-spectrum cephalosporin-resistant isolates of E. coli and Salmonella from animals, 35 CMY-2 was detected in six out of the 26 isolates. Moreover, in the positive isolates tested (five Salmonella Agona and one Salmonella Kentucky), the bla CMY-2 gene was always located on IncI1 plasmids, as described for some Salmonella and E. coli isolates from different origins. 39 This differs from reports on isolates from the USA and the UK, where most of the plasmids containing bla CMY-2 belonged to Inc group A/C. 39, 40, 47 Finally, and due to the data from XbaI PFGE and plasmid profiles together with the almost identical resistance phenotypes and genotypes, it can be concluded that the Salmonella Agona isolates belonged to the same clonal line that could be isolated in different German regions and/or periods.
The spread of multidrug-resistant isolates producing ESBLs or AmpC, especially when they also carry other emerging determinants conferring high resistance to aminoglycosides (such as arm genes), resistance to fluoroquinolones (such as plasmid located qnr genes) or integrons, is currently of concern, because co-selection of resistance by the use of different antimicrobials can occur. 10, 11 Among the 26 ESBLs and AmpC isolates found in our study, 22 were also resistant to non-b-lactam antimicrobials (Table 1 ) and carried several resistance determinants, including integrons. Three isolates (11% of the positive), all of them originating from poultry and encoding different b-lactamases (CMY-2, TEM-52 and TEM-20) were resistant to quinolones with reduced susceptibility to fluoroquinolones (ciprofloxacin MIC of 0.25 -1 mg/L). This co-resistance is a worrying trend that is increasingly detected in other European countries, 10 and in German Salmonella and E. coli poultry isolates from 2008 -09 (B. Guerra, unpublished data), and seems to be frequent in other studies on clinical isolates (i.e. 72% of the ESBLs isolates found among human German E. coli isolates by Pfeifer). 48 No emerging qnrA, qnrB or qnrS, aac(6)-Ib-cr or armA genes could be detected among the 26 Salmonella isolates. However, in other E. coli series analysed in our laboratories we found several isolates harbouring bla CTX-M-1 /qnrS1 or bla CTX-M-15 /aac(6 0 )-Ib-cr located on the same plasmids (B. Guerra, unpublished data).
Seven Salmonella Typhimurium isolates, four of them isolated from horses, were positive for the presence of the SGI1-M. This variant, previously detected in one Salmonella Typhimurium isolate also from a horse in the Netherlands, contains the resistance gene cluster aadB-sul1-floR-tet(G)-bla PSE-1 , where the aadA2 gene of the first integron of SGI1 was replaced by the aadB gene. 31 However, three out of the seven isolates were also positive for other resistance genes (aadA1, strA-strB, sul2) and all of them harboured, in addition, a conjugative plasmid containing the genes encoding the CTX-M-1 or CTX-M-15 ESBLs (Table 1) . On the other hand, two Salmonella Typhimurium definitive phage-type 193 (DT193) CTX-M-1 producers, one isolated from swine and one from human, shared the same PFGE pattern, plasmid profile and resistance genotype. These strains could have been implicated in an outbreak that occurred in 2007 in a German region (W. Rabsch, Robert Koch Institute, personal communication).
With regard to class 2 integrons, only the variable region 2300 bp/dfrA1-sat2-aadA1 was detected in all Salmonella Paratyphi B dTþ isolates analysed in this work, irrespective of the kind of b-lactamase they harboured. All of them shared a common XbaI PFGE pattern, characteristic of the German clone described previously, 32 in which the class 2 integron is chromosomally located. Our results show that this clone has evolved over time, with a subsequent acquisition of plasmids containing different ESBL-encoding genes. In fact, at the NRL-Salm, during 2008, other Salmonella Paratyphi B dTþ isolates belonging to this clone, and harbouring bla CTX-M-2 , bla CTX-M-1 and bla ACC-1 , all of them originating from poultry or poultry products, were detected (B. Guerra, unpublished data).
In conclusion, this study describes the current situation with ESBL and AmpC producers in S. enterica isolates mainly from animal and food origin collected all over Germany. It must be emphasized that, in comparison with Eastern and Southern European countries, both resistance determinants are still only sporadically detected. Their dissemination is linked to the spread of successful and endemic clonal lines, namely Salmonella Typhimurium, Salmonella Paratyphi B dTþ and Salmonella Agona. However, we notice that the number of positive isolates is increasing and most of them belong to Salmonella Paratyphi B dTþ from poultry/poultry foods, carrying different b-lactamases. Our data also underline the important role of horizontal gene transfer for spreading these resistance mechanisms. Because of the clinical importance of third-and fourthgeneration b-lactams in human and veterinary medicine, our findings describe the onset of a public health problem, especially in zoonotic pathogens.
